Product Recall: Artis PL E and Artis Symbiose Intraocular Lenses
Summary
The French National Agency for the Safety of Medicines and Health Products (ANSM) has announced a product recall for Artis PL E and Artis Symbiose intraocular lenses manufactured by Cristalens Industrie. This safety action, registered under number R2606056, requires healthcare facilities to take immediate action regarding the affected lots.
What changed
The ANSM has issued a safety alert regarding a product recall of Artis PL E and Artis Symbiose intraocular lenses, initiated by Cristalens Industrie. The recall is identified under ANSM safety action number R2606056. Healthcare facilities that received the associated notification letter are directly involved in this action.
Healthcare providers must immediately cease use of the affected intraocular lenses and follow the instructions provided by Cristalens Industrie. While no specific compliance deadline is stated, the nature of a product recall implies an immediate need for action to prevent patient harm. Further questions should be directed to the manufacturer.
What to do next
- Cease use of affected Artis PL E and Artis Symbiose intraocular lenses.
- Consult the notification letter from Cristalens Industrie for specific instructions.
- Direct any questions to Cristalens Industrie.
Archived snapshot
Mar 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Rappel n° R2606056 destiné aux établissements de santé L'ANSM a été informée de la mise en œuvre d’un retrait de lot effectué par la société Cristalens Industrie.
Les établissements de santé concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2606056.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Cristalens Industrie (19/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.